Assembly Biosciences ASMB Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $58.45M+52.4% | $38.34M+93.3% | $19.84M-62.1% | $52.42M+14.9% | ||
| $189.66M+157% | $73.74M-33.2% | $110.41M+182% | $39.19M-61.2% | ||
| $974K— | $0-100% | $43K-95.4% | $944K+181% | ||
| $5.47M+59.7% | $3.42M-2.1% | $3.5M-20.8% | $4.41M-39.1% | ||
| $254.55M+120% | $115.5M-13.7% | $133.79M+38.0% | $96.97M-37.1% | ||
| $221K-22.2% | $284K-26.2% | $385K-48.2% | $743K-34.8% | ||
| $2.51M-18.3% | $3.07M+31.2% | $2.34M-26.8% | $3.2M-47.1% | ||
| $312K0.0% | $312K0.0% | $312K-64.9% | $889K-47.8% | ||
| $257.59M+116% | $119.17M-12.9% | $136.82M+34.4% | $101.79M-46.7% | ||
| $1.17M+100% | $585K+26.9% | $461K-81.5% | $2.49M-6.2% | ||
| $7.75M+12.9% | $6.86M+19.5% | $5.74M-21.5% | $7.32M+6.6% | ||
| $36.9M-1.9% | $37.62M+21.7% | $30.92M— | —— | ||
| $569K+23.4% | $461K-62.2% | $1.22M-63.7% | $3.36M+6.8% | ||
| $48.78M+2.0% | $47.8M+21.9% | $39.23M+141% | $16.3M+1.4% | ||
| $2.06M-21.7% | $2.63M+134% | $1.12M+1,011% | $101K-97.0% | ||
| $50.84M-40.8% | $85.81M-10.4% | $95.73M+400% | $19.13M-13.6% | ||
| —— | —— | —— | —— | ||
| $16K+129% | $7K+40.0% | $5K+25.0% | $4K-91.7% | ||
| $1.04B+20.9% | $859.49M+3.9% | $826.92M+2.3% | $807.98M+0.9% | ||
| -$832.05M-0.7% | -$825.93M-5.1% | -$785.75M-8.5% | -$724.52M-14.7% | ||
| -$41K+80.6% | -$211K-160% | -$81K+89.9% | -$803K-91.6% | ||
| $206.75M+520% | $33.36M-18.8% | $41.1M-50.3% | $82.66M-51.1% | ||
| $257.59M+116% | $119.17M-12.9% | $136.82M+34.4% | $101.79M-46.7% | ||
| $189.66M+157% | $73.74M-33.2% | $110.41M+182% | $39.19M-61.2% | ||
| $312K0.0% | $312K0.0% | $312K-64.9% | $889K-47.8% | ||
| $2.51M-18.3% | $3.07M+31.2% | $2.34M-26.8% | $3.2M-47.1% | ||
| $2.51M-18.3% | $3.07M+31.2% | $2.34M-26.8% | $3.2M-47.1% | ||
| $312K0.0% | $312K0.0% | $312K-64.9% | $889K-47.8% | ||
| $2.51M-18.3% | $3.07M+31.2% | $2.34M-26.8% | $3.2M-47.1% | ||
| $312K0.0% | $312K0.0% | $312K-64.9% | $889K-47.8% | ||
| $2.39M+5.0% | $2.27M+157% | $885K-71.7% | $3.12M-8.2% | ||
| $2.63M-14.9% | $3.09M+31.9% | $2.34M-32.4% | $3.47M-46.5% | ||
| $1.04B+20.9% | $859.49M+3.9% | $826.92M+2.3% | $807.98M+0.9% | ||
| $16K+129% | $7K+40.0% | $5K+25.0% | $4K-91.7% | ||
| $7.75M+12.9% | $6.86M+19.5% | $5.74M-21.5% | $7.32M+6.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Assembly Biosciences's total assets?
- Assembly Biosciences (ASMB) holds $235.5M in total assets, up 137.8% year over year.
- How much debt does Assembly Biosciences have?
- Assembly Biosciences carries $2.5M in total debt against $198.6M of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does Assembly Biosciences have?
- Assembly Biosciences holds $31.1M in cash and equivalents.
- Can Assembly Biosciences cover its short-term obligations?
- Its current ratio is 6.65 — current assets exceed current liabilities.
- Where does Assembly Biosciences's balance sheet data come from?
- Every line is extracted from Assembly Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
